{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:23:37Z","timestamp":1768069417530,"version":"3.49.0"},"reference-count":62,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"5","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2133\/dmpk.dmpk-10-rg-049","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T01:20:22Z","timestamp":1285809622000},"page":"430-441","source":"Crossref","is-referenced-by-count":17,"title":["Lack of a Primary Physicochemical Determinant in the Direct Transport of Drugs to the Brain after Nasal Administration in Rats: Potential Involvement of Transporters in the Pathway"],"prefix":"10.2133","volume":"25","author":[{"given":"Kyeong-Ryoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Byung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeho","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Duk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Koo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk-Jae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567201053586047","article-title":"Intranasal drug delivery for brain targeting","volume":"2","author":"Vyas","year":"2005","journal-title":"Curr. Drug Del."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood\u2013brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0020","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter-mediated permeation of drugs across the blood\u2013brain barrier","volume":"89","author":"Tamai","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1359-6446(00)01643-3","article-title":"Efflux transport systems for drugs at the blood\u2013brain barrier and blood-cerebrospinal fluid barrier (Part 2)","volume":"6","author":"Kusuhara","year":"2001","journal-title":"Drug Discovery Today"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0035","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/0024-3205(88)90351-7","article-title":"A new aspect of the protective functions of the blood\u2013brain barrier: Activities of four drug-metabolizing enzymes in isolated rat brain microvessels","volume":"42","author":"Ghersi-Egea","year":"1988","journal-title":"Life Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0378-4274(95)03510-9","article-title":"Blood\u2013brain interfaces: relevance to cerebral drug metabolism","volume":"82","author":"Ghersi-Egea","year":"1995","journal-title":"Toxicol. Lett"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2004.11.006","article-title":"A novel method to calculate the extent and amount of drug transported into CSF after intranasal administration","volume":"289","author":"Shi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"Turker","year":"2004","journal-title":"Pharm. World Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-3659(98)00115-1","article-title":"The effect of methylated [beta]-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: Electron microscopic and confocal laser scanning microscopic visualization studies","volume":"57","author":"Marttin","year":"1999","journal-title":"J. Controlled Release"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0065","first-page":"140","article-title":"Intranasal delivery: An approach to bypass the blood brain barrier","volume":"36","author":"Talegaonkar","year":"2004","journal-title":"Ind. J. Pharmcol."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.58.1.0008","article-title":"Carbamaze-pine uptake into rat brain following intra-olfactory transport","volume":"58","author":"Barakat","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following in-tranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-[beta] to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1023\/A:1007542618378","article-title":"Transfer of dopamine in the olfactory pathway following nasal administration in mice","volume":"17","author":"Dahlin","year":"2000","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0095","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10717549709051892","article-title":"Olfactory absorption of insulin to the brain","volume":"4","author":"Sigurdsson","year":"1997","journal-title":"Drug Deliv."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jps.20480","article-title":"Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting","volume":"95","author":"Vyas","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1211\/jpp.58.6.0014","article-title":"Application of a sample pooling method for the accelerated assessment of the rate of up-take of drugs by the brain in rats","volume":"58","author":"Kim","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-0270(02)00033-X","article-title":"Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity","volume":"116","author":"Van Den Berg","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2003.10.012","article-title":"The potential of nasal application for delivery to the central brain\u2014a microdialysis study of fluorescein in rats","volume":"21","author":"Bagger","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2007.03.039","article-title":"UEA I-bearing nanoparticles for brain delivery following intranasal administration","volume":"340","author":"Gao","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0130","series-title":"Guidancefor industry: bioanalytical method validation","author":"FDA","year":"2001"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0135","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/rcm.2718","article-title":"Rapid and sensitive determination of donepezil in human plasma by liquid chromatography\/tandem mass spectrometry: application to a pharmacokinetic study","volume":"20","author":"Xie","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0140","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/jps.21895","article-title":"Evidence of carrier-mediated transport in the penetration of donepezil into the rat brain","volume":"99","author":"Kim","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00418-008-0410-2","article-title":"Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat","volume":"130","author":"Wolburg","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11095-004-9013-3","article-title":"Functional evidence for P-glycoprotein at the nose-brain barrier","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jps.10546","article-title":"Pharmacokinetic characterization of dehydroevodiamine in the rat brain","volume":"93","author":"Ahn","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(98)00061-1","article-title":"The distribution of local anesthetics into the CSF following intranasal administration","volume":"168","author":"Chou","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.physiol.60.1.243","article-title":"Organic cation transporters in intestine, kidney, liver, and brain","volume":"60","author":"Koepsell","year":"1998","journal-title":"Annu. Rev. Physiol"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0170","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1016086003070","article-title":"Carrier-mediated intestinal transport of drugs","volume":"13","author":"Tsuji","year":"1996","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0175","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1124\/jpet.105.094052","article-title":"Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists","volume":"316","author":"Tahara","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0185","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1463-1326.2009.01076.x","article-title":"Interaction of beta-blockers with the renal uptake transporter OCT2","volume":"11","author":"Bachmakov","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0190","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00431.2009","article-title":"Human multidrug and toxin extrusion 1 (MATE1\/SLC47A1) transporter: Functional characterization, interaction with OCT2, and single nucleotide polymorphisms","volume":"298","author":"zu Schwabedissen","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0195","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pfugers Arch."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0200","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.addr.2004.07.013","article-title":"A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat","volume":"56","author":"Hosoya","year":"2004","journal-title":"Adv. Drug Del. Rev."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0205","first-page":"427","article-title":"Nasal delivery","volume":"3","author":"Illum","year":"1996","journal-title":"The use of animal models to predict performance in man. J. Drug Targeting"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(03)00129-7","article-title":"The human bronchial epithelial cell line 16HBE14o-as a model system of the airways for studying drug transport","volume":"257","author":"Forbes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2007.03.030","article-title":"Influence of membrane-solvent-solute interactions on solute permeation in skin","volume":"340","author":"Dias","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0003-2670(99)00127-0","article-title":"Simultaneous quantitative determination of diazepam and liposomes using differential pulse polarography","volume":"391","author":"Kontoyannis","year":"1999","journal-title":"Anal. Chim. Acta"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0230","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jpba.2008.09.029","article-title":"Association mechanism of four acetylcholinesterase inhibitors (AChEIs) with human serum albumin: A biochromatographic approach","volume":"48","author":"Ibrahim","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0235","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s11095-009-9876-4","article-title":"Assessment of blood-brain barrier permeability using the in situ mouse brain perfusion technique","volume":"26","author":"Zhao","year":"2009","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0240","series-title":"Physicochemical parameters as tools in drug discovery and lead optimization","author":"Faller","year":"2001"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0245","series-title":"Advances in chromatography","author":"Giddings","year":"1989"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/DDC-120028713","article-title":"Biopharmaceutics classification by high throughput solubility assay and PAMPA","volume":"30","author":"Obata","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/138620709787581693","article-title":"Simultaneous determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector","volume":"12","author":"Chiang","year":"2009","journal-title":"Combinatorial Chem. High Throughput Screening"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0260","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/dmd.30.12.1497","article-title":"The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties","volume":"30","author":"Austin","year":"2002","journal-title":"Drug Metab. Disposition"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0265","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1021\/ci049884m","article-title":"ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties","volume":"44","author":"Hou","year":"2004","journal-title":"J. Chem. Inf Comput. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0270","series-title":"Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability","author":"Van De Waterbeemd","year":"2003"},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(95)04259-8","article-title":"Transfer of metformin across monolayers of human intestinal Caco-2 cells and across rat intestine","volume":"128","author":"Nicklin","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(01)00845-6","article-title":"Optimized conditions of bio-mimetic artificial membrane permeation assay","volume":"228","author":"Sugano","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0285","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease","volume":"52","author":"Arce","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0290","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/mp8002495","article-title":"Mechanistic modeling of hepatic transport from cells to whole body: Application to napsagatran and fexofenadine","volume":"6","author":"Poirier","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0295","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pd.2026","article-title":"Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model","volume":"28","author":"Kovo","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0300","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1023\/B:PHAM.0000003380.44755.5a","article-title":"In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography\/mass spectrometry detection","volume":"20","author":"Liu","year":"2003","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0305","first-page":"365","article-title":"PAMPA\u2014a drug absorption in vitro model 11","volume":"22","author":"Avdeef","year":"2004","journal-title":"Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-10-RG-049_bb0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-010-9176-2","article-title":"Comparison of drug permeabilities and BCS classification: Three lipid-component PAMPA system method versus Caco-2 monolayers","volume":"12","author":"Teksin","year":"2010","journal-title":"AAPS J."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715300537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715300537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:34:31Z","timestamp":1559694871000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715300537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1347436715300537"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-10-rg-049","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}